Itherapeutics Corp is categorized under Research and Development Laboratories in Boca Raton, FL and active since 2006.
Itherapeutics Corp was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact Rhys Williams, Manager at the company’s single location by writing to 3651 Fau Boulevard # 400, Boca Raton, Florida FL 33431 or by phoning (561) 542-1380. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Itherapeutics Corp |
| Contact Person: | Rhys Williams, Manager |
| Address: | 3651 Fau Boulevard # 400, Boca Raton, Florida 33431 |
| Phone Number: | (561) 542-1380 |
| Website Address: | itherapeutics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Itherapeutics Corp was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Rhys Williams, Manager for inquiries that concern Itherapeutics Corp by calling the company number (561) 542-1380, as your correspondence is most welcome. Additionally, the physical location of the single location of Itherapeutics Corp can be found at the coordinates 26.38341,-80.09803 as well as the street address 3651 Fau Boulevard # 400 in Boca Raton, Florida 33431.
For its online presence, you may visit Itherapeutics Corp’s website at itherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.